A Cost Model for a Low-Threshold Clinic Treating Opioid Use Disorder

被引:0
|
作者
Wakeman, Sarah E. [1 ]
Powell, Elizabeth [2 ]
Shehab, Syed [3 ]
Herman, Grace [4 ]
Kehoe, Laura [1 ]
Kaplan, Robert S. [3 ,5 ]
机构
[1] Massachusetts Gen Hosp, Dept Med, Boston, MA USA
[2] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA USA
[3] Harvard Univ, Cambridge, MA USA
[4] Univ Buffalo, Jacobs Sch Med, Buffalo, NY USA
[5] Harvard Sch Business, Boston, MA 02163 USA
关键词
BUPRENORPHINE; PEOPLE;
D O I
10.1007/s11414-023-09853-4
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The US fee-for-service payment system under-reimburses clinics offering access to comprehensive treatments for opioid use disorder (OUD). The funding shortfall limits a clinic's ability to expand and improve access, especially for socially marginalized patients with OUD. New payment models, however, should reflect the high variation in cost for using a clinic's clinical and voluntary psychosocial and recovery support services. The authors applied time-driven activity-based costing, a patient-level, micro-costing approach, to estimate the cost at an outpatient clinic that delivers medication for opiate used disorder (MOUD) and voluntary psychosocial and recovery support services. Much of the cost variation could be explained by classifying patients into three archetypes: (1) light touch (1-3 visits): no significant co-occurring psychiatric illness, stable housing, and easy to connect for ongoing OUD treatment in a traditional outpatient setting; (2) standard (average of 8 visits): initially requires an integrated team-based care model but soon stabilizes for transition to community-based outpatient care; (3) quad morbidity (> 20 visits): multiple co-occurring substance use disorders, unhoused, co-occurring medical and psychiatric complexity, and limited social supports. With the cost of the initial visit set at an indexed value of 100, an average light touch patient had a cost of 352, a standard patient was 718, and a quad morbidity patient was 1701. The cost structure revealed by this analysis provides the foundation for alternative payment models that would enable new MOUD clinics, staffed with multi-disciplinary care teams, and located for convenient access by high-risk patients, to be established and sustained.
引用
收藏
页码:22 / 30
页数:9
相关论文
共 50 条
  • [41] The association of medical providers' attitudes about naloxone and treating people with opioid use disorder and their self-reported low-barrier treatment practices
    Winograd, Rachel P.
    Coffey, Bridget
    Nance, Melissa
    Carpenter, Ryan
    ADDICTIVE BEHAVIORS REPORTS, 2023, 18
  • [42] Barriers to medications for opioid use disorder in the court system: provider availability, provider “trustworthiness,” and cost
    Fatema Z. Ahmed
    Barbara Andraka-Christou
    M.H. Clark
    Rachel Totaram
    Danielle N. Atkins
    Brandon del Pozo
    Health & Justice, 10
  • [43] Implementation of methadone therapy for opioid use disorder in Russia - a modeled cost-effectiveness analysis
    Idrisov, Bulat
    Murphy, Sean M.
    Morrill, Tyler
    Saadoun, Mayada
    Lunze, Karsten
    Shepard, Donald
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2017, 12
  • [44] Barriers to medications for opioid use disorder in the court system: provider availability, provider "trustworthiness," and cost
    Ahmed, Fatema Z.
    Andraka-Christou, Barbara
    Clark, M. H.
    Totaram, Rachel
    Atkins, Danielle N.
    del Pozo, Brandon
    HEALTH & JUSTICE, 2022, 10 (01)
  • [45] Comparison of Rural vs Urban Direct-to-Physician Commercial Promotion of Medications for Treating Opioid Use Disorder
    Thuy Nguyen
    Andraka-Christou, Barbara
    Simon, Kosali
    Bradford, W. David
    JAMA NETWORK OPEN, 2019, 2 (12) : E1916520
  • [46] Mental Health and Psychosocial Needs of Patients Being Treated for Opioid Use Disorder in a Primary Care Residency Clinic
    Hooker, Stephanie A.
    Sherman, Michelle D.
    Lonergan-Cullum, Mary
    Sattler, Adam
    Liese, Bruce S.
    Justesen, Kathryn
    Nissly, Tanner
    Levy, Robert
    JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2020, 11
  • [47] Rapid Low-dose Buprenorphine Initiation for Hospitalized Patients With Opioid Use Disorder
    Sokolski, Eleasa
    Skogrand, Emily
    Goff, Amelia
    Englander, Honora
    JOURNAL OF ADDICTION MEDICINE, 2023, 17 (04) : E278 - E280
  • [48] Outcomes of Emergency Department Patients With Opioid Use Disorder Utilizing a Virtual Addiction Bridge Clinic: A Case Series
    Wills, Brandon K.
    Ringwood, Katy J.
    Davis, Theresa T.
    Provost, Rosellen
    Bachireddy, Chethan
    Wang, Jennifer
    Keyser-Marcus, Lori
    Moeller, F. Gerard
    JOURNAL OF ADDICTION MEDICINE, 2023, 17 (06) : 729 - 731
  • [49] Relative Cost Differences of Initial Treatment Strategies for Newly Diagnosed Opioid Use Disorder A Cohort Study
    Larochelle, Marc R.
    Wakeman, Sarah E.
    Ameli, Omid
    Chaisson, Christine E.
    McPheeters, Jeffrey T.
    Crown, William H.
    Azocar, Francisca
    Sanghavi, Darshak M.
    MEDICAL CARE, 2020, 58 (10) : 919 - 926
  • [50] An economic analysis of the cost of mobile units for harm reduction, naloxone distribution, and medications for opioid use disorder
    Castry, Mathieu
    Tin, Yjuliana
    Feder, Noah M.
    Lewis, Nikki
    Chatterjee, Avik
    Rudorf, Maria
    Samet, Jeffrey H.
    Beers, Donna
    Medley, Bethany
    Gilbert, Louisa
    Linas, Benjamin P.
    Barocas, Joshua A.
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2024, 167